Autologous bone marrow stem cell transplantation in patients with end-stage chronical critical limb ischemia and diabetic foot

Vnitrni Lekarstvi

Volumn 55, Issue 3, 2009, Pages 173-178

  Prochazka V ^a   Gumulec, J ^b   Chmelova J ^a   Klement, P ^c   Klement, G L ^d   Jonszta, T ^a   Czerny D ^a   Krajca J ^a  

^a UNIVERSITY HOSPITAL OSTRAVA   (Czech Republic)

^b Hospital Ostrava Poruba   (Czech Republic)

^c MCMASTER UNIVERSITY   (Canada)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Bon marrow stem cells; Critical limb ischemia; Diabetic foot; Transplantation

Indexed keywords

ADULT; AGED; ANGIOGENESIS; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC FOOT; FOOT AMPUTATION; GANGRENE; HUMAN; HYPOXIA; LASER DOPPLER FLOWMETRY; LIMB ISCHEMIA; LIMB SALVAGE; OXIMETRY; TREATMENT OUTCOME; VENOUS BLOOD; WOUND HEALING;

ADULT; AGED; BLOOD FLOW VELOCITY; BLOOD GAS ANALYSIS; BONE MARROW TRANSPLANTATION; DIABETIC FOOT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; ISCHEMIA; LASER-DOPPLER FLOWMETRY; LEG; LIMB SALVAGE; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; TRANSPLANTATION, AUTOLOGOUS;

EID: 63849256381     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Cipolleschi MG, Dello Sbarba P, Olivotto M. The Role of Hypoxia in the Maintenance of Hematopoietic Stem Cells. Blood 1993;82:2031-2037.
2. AsaharaT, Masuda H,Takahaski T et al. Bone Marrow Origin of Endothelial Progenitor Cells Responsible for Postnatal Vasculogenesis in Physiological and Pathological Neovascularization. Circ Res 1999; 85: 221-228.
3. Shintani S, MuroharaT, Ikeda H et al. Augmentation of Postnatal Neovascularization with Autologous Bone Marrow Transplantation. Circulation 2001; 103: 897-903.
4. MurayamaT, Tepper OM, Silver M et al. Determination of Bone Marrow-Derived Progenitor Cell Significance in Angiogenic Growth Factor-Induced Neovascularization in Vivo. Exp Hematol 2002; 30: 967-972.
5. Rafii S, Lyden D. Therapeutic Stem Progenitor Cell Transplantation for Organ Vascularization and Regeneration. Nat Med 2003;9:702-712.
6. Tepper O, Capla JM, Galiano RD et al. Adult Vasculogenesis Occurs Through in Situ Recruitment, Proliferation, and Tubulization of Circulating Bone Marrow-Derived Cells. Blood 2005; 95: 1068-1077.
7. Urbich C, Dimmeler S. Current Progenitor Cells: Characterization and Role in Vascular Biology. Circ Res 2004; 95: 343-353.
8. Hamano K, Li TS, Kobayashi T, Tanaka N et al. The Induction of Angiogenesis by the Implantation of Autologous Bone Marrow Cells: A Novel and Simple Therapeutic Method. Surgery 2001; 130: 44-54.
9. Yuyama E, Matsubara H, Murohara T et al. Therapeutic Angiogenesis for Patients with Limb Ischemia by Autologous Transplantation of Bone-Marrow Cells: A Pilot Study and a Randomised Controlled Trial. Lancet 2002; 360: 427-435.
10. Esato K, Hamano K, Li TS et al. Neovascularization Induced by Autlogous Bone Marrow Cell Implantation in Peripheral Arterial Disease. Cell Transplant 2002; 11: 747-752.
11. Al-Khaldi A, Al-Sabti H, Galipeau J et al. Therapeutic Angiogenesis Using Autlogous Bone Marrow Stromal Cells: Improved Blood Flow in a Chronic Limb Ischemia Model. Ann Thorac Surg 2003; 75: 204-209.
12. Saigawa T, Kato K, Ozawa et al. Clinical Application of Bone Marrow Implantation in Patients with Arteriosclerosis Obliterans, and the Association between Efficacy and the Number of Implanted Bone Marrow Cells. Circ J 2004; 68: 1189-1193.
13. Amann B, Lüdemann C, Rückert R et al. Design and rationale of a randomized, double-blind, placebo-controlled phase III study for autologous bone marrow cell transplantation in critical limb ischemia. The Bone Marrow Stem Outcomes trial in Critical limb Ischemia (BONMOT-CLI). Vasa 2008; 37: 319-325.